One of the biggest advantages of the new polymer-based nanoparticles over current lipid-based models is the potential for low ...

UTR Therapeutics plans to initiate a Phase 1 trial of UTRxM1-18 in patients with advanced c-MYC–driven tumors pending regulatory approvals. The company is also exploring translational and commercial ...

Researchers at the University of California, Davis, have been awarded a $3 million National Science Foundation grant to ...

The field of microbiology has emerged as a cornerstone for green technology, playing a crucial role in fostering sustainable ...

Some researchers are calling for strict limits, while others speak out against prematurely halting basic science.

Bacteria have long been a key source of lifesaving antibiotics, but most species cannot be grown in the lab—leaving their ...

Students are worried about the removal of the Additional Subject Exam option in exam forms, as it previously allowed them to ...

University of Sheffield is inviting applications for BSc Biomedical course that starts from September 2026. The course ...

Simulations Plus, Inc. ( NASDAQ: SLP) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 2:35 PM EDT Well, thank you, everybody, for being here today. I'm delighted to ...

Avidity Biosciences, Inc. ( NASDAQ: RNA) Discusses on Redefining the Treatment of Duchenne Muscular Dystrophy Conference Call September 10, 2025 8:00 AM EDT ...

Caza Innovations, a high-growth research and technology firm specializing in commercial applications of advanced materials, ...